As of the latest SEC filings, LENZ Therapeutics, Inc. (LENZ) is held by 139 institutional funds. The largest fund shareholder is Fidelity Growth Company Fund (FGCKX), holding an estimated $16,574,259.17 in market value, representing 0.02% of its portfolio.
Funds holding LENZ Therapeutics, Inc. (LENZ)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- LENZ
- CIK:
- 0001815776
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.02% | $16,574,259.17 | 1,228,633 | Feb 28, 2026 | Apr 24, 2026 |
|
HQH
abrdn Healthcare Investors
|
CEF | abrdn / Aberdeen | 0.63% | $7,177,131.90 | 784,386 | Mar 31, 2026 | May 29, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $6,973,709.10 | 762,154 | Mar 31, 2026 | May 28, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.02% | $4,884,729.00 | 362,100 | Feb 28, 2026 | Apr 24, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.01% | $4,399,365.75 | 480,805 | Mar 31, 2026 | May 28, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.02% | $4,278,232.09 | 317,141 | Feb 28, 2026 | Apr 24, 2026 |
|
POAGX
PRIMECAP Odyssey Aggressive Growth Fund
|
MF | Independent / Boutique | 0.05% | $3,649,472.00 | 406,400 | Apr 30, 2026 | Jun 29, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 0.61% | $3,401,741.25 | 371,775 | Mar 31, 2026 | May 29, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $2,324,081.70 | 253,998 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.02% | $1,893,784.65 | 206,971 | Mar 31, 2026 | May 28, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.01% | $1,780,195.20 | 198,240 | Apr 30, 2026 | Jun 26, 2026 |
|
FBTDX
Franklin Biotechnology Discovery Fund
|
MF | Franklin Templeton | 0.16% | $1,678,424.86 | 186,907 | Apr 30, 2026 | Jun 24, 2026 |
|
PRJIX
T. Rowe Price New Horizons Fund, Inc.
|
MF | T. Rowe Price | 0.01% | $1,596,034.50 | 174,430 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $1,570,357.41 | 116,409 | Feb 28, 2026 | Apr 24, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.01% | $1,485,758.70 | 162,378 | Mar 31, 2026 | May 28, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.01% | $1,423,707.62 | 105,538 | Feb 28, 2026 | Apr 24, 2026 |
|
FSSAX
Franklin Small Cap Growth Fund
|
MF | Franklin Templeton | 0.06% | $1,397,476.58 | 155,621 | Apr 30, 2026 | Jun 24, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.01% | $1,324,471.65 | 144,751 | Mar 31, 2026 | May 28, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.01% | $1,076,758.31 | 79,819 | Feb 28, 2026 | Apr 28, 2026 |
|
PRDSX
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund
|
MF | T. Rowe Price | 0.01% | $701,484.75 | 76,665 | Mar 31, 2026 | May 28, 2026 |
|
IHE
iShares U.S. Pharmaceuticals ETF
|
ETF | BlackRock / iShares | 0.06% | $560,153.85 | 61,219 | Mar 31, 2026 | May 22, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $532,612.18 | 39,482 | Feb 28, 2026 | Apr 24, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.01% | $513,402.42 | 38,058 | Feb 28, 2026 | Apr 24, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.00% | $474,416.32 | 35,168 | Feb 28, 2026 | Apr 28, 2026 |
|
BBP
Virtus Biotech Etf
|
ETF | Independent / Boutique | 0.79% | $468,486.60 | 52,170 | Apr 30, 2026 | Jun 22, 2026 |
Advertisement (320x50)